|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Note receivable | ||||||||||||||||||||
| Fixed Assets | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable – nonrelated party | ||||||||||||||||||||
| Accrued settlement | ||||||||||||||||||||
| Accounts Payable and accrued expenses - related party | ||||||||||||||||||||
| Accrued expenses and Accrued interest – nonrelated party | ||||||||||||||||||||
| Accounts payable – related party | ||||||||||||||||||||
| Accrued expenses and Accrued interest – related party | ||||||||||||||||||||
| Bank overdraft | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Convertible notes payable, current | ||||||||||||||||||||
| Convertible notes payable, related party, net of discount of $0 and $0 | ||||||||||||||||||||
| Notes payable, current, net of original issue discount of $4,077 and $0 | ||||||||||||||||||||
| Notes payable, related party | ||||||||||||||||||||
| Convertible notes payable, related party, net of discount | ||||||||||||||||||||
| Notes payable, current, net of original issue discount of $0 and $4,077 | ||||||||||||||||||||
| Loan payable, current | ||||||||||||||||||||
| Convertible notes payable, related party | ||||||||||||||||||||
| Loans payable, current | ||||||||||||||||||||
| Note payable, former related party | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Loan payable, noncurrent | ||||||||||||||||||||
| Loans payable, noncurrent | ||||||||||||||||||||
| Convertible notes payable, Non current | ||||||||||||||||||||
| Notes payable, noncurrent | ||||||||||||||||||||
| Total noncurrent liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Preferred stock value | ||||||||||||||||||||
| Common stock, $0.00001 par value; 30,000,000,000 shares authorized; 24,417,866,769 and 20,217,870,775 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Treasury stock, at cost; 8 shares at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Stock loan receivable | ||||||||||||||||||||
| Shares to be cancelled | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||||
| Non-Controlling Interest | ||||||||||||||||||||
| Total stockholders’ deficit attributable to GBT Technologies, Inc. | ||||||||||||||||||||
| Total liabilities and stockholders’ deficit | ||||||||||||||||||||
Loading...